Here, we found that IL25 expression is negatively correlated with survival of human NSCLC patients, that ILC2 cells are elevated in human NSCLC patients and that IL25-activated murine ILC2 cells promote lung tumor growth and metastasis while reducing survival of tumor-bearing mice. Here, IL25 is linked to non-small cell lung carcinoma.